Literature DB >> 10606759

Expression of factor X in both the rat brain and cells of the central nervous system.

Y Shikamoto1, T Morita.   

Abstract

Prothrombin is expressed in the central and peripheral nervous systems. However, the mechanism responsible for the activation of prothrombin to thrombin by the activated form of factor X in the central and peripheral nervous systems remains to be explored. Here, we investigated the expression of factor X mRNA in the brain and some cell lines derived from the central nervous system. Reverse transcription-polymerase chain reaction (RT-PCR) demonstrated the expression of mRNA encoding factor X in the rat brain, A172 (human glioblastoma) and GOTO (human neuroblastoma) cells. The sequences of PCR-derived fragments were identical to those reported for rat and human factor X. These results indicated the synthesis of factor X in the cells of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606759     DOI: 10.1016/s0014-5793(99)01657-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

2.  The pro-migratory and pro-invasive role of the procoagulant tissue factor in malignant gliomas.

Authors:  Stephan Dützmann; Florian Gessler; Patrick N Harter; Rüdiger Gerlach; Michel Mittelbronn; Volker Seifert; Donat Kögel
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

3.  Neuron-generated thrombin induces a protective astrocyte response via protease activated receptors.

Authors:  Padmesh S Rajput; Jessica Lamb; Shweta Kothari; Benedict Pereira; Daniel Soetkamp; Yizhou Wang; Jie Tang; Jennifer E Van Eyk; Eric S Mullins; Patrick D Lyden
Journal:  Glia       Date:  2019-08-27       Impact factor: 7.452

4.  HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by Furin.

Authors:  Vatsal Sachan; Robert Lodge; Koichiro Mihara; Josée Hamelin; Christopher Power; Benjamin B Gelman; Morley D Hollenberg; Éric A Cohen; Nabil G Seidah
Journal:  Cell Death Differ       Date:  2019-01-25       Impact factor: 15.828

5.  Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition.

Authors:  Tao Chen; Jing Wang; Chenhui Li; Weining Zhang; Luyong Zhang; Lufan An; Tao Pang; Xinzhong Shi; Hong Liao
Journal:  Sci Rep       Date:  2014-07-02       Impact factor: 4.379

6.  Thrombin induces ischemic LTP (iLTP): implications for synaptic plasticity in the acute phase of ischemic stroke.

Authors:  Efrat Shavit Stein; Zeev Itsekson-Hayosh; Anna Aronovich; Yair Reisner; Doron Bushi; Chaim G Pick; David Tanne; Joab Chapman; Andreas Vlachos; Nicola Maggio
Journal:  Sci Rep       Date:  2015-01-21       Impact factor: 4.379

7.  EGFR is a pivotal regulator of thrombin-mediated inflammation in primary human nucleus pulposus culture.

Authors:  Bor-Ren Huang; Tzu-Sheng Chen; Da-Tian Bau; I-Chen Chuang; Cheng-Fang Tsai; Pei-Chun Chang; Dah-Yuu Lu
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

Review 8.  The Importance of Thrombin in Cerebral Injury and Disease.

Authors:  Harald Krenzlin; Viola Lorenz; Sven Danckwardt; Oliver Kempski; Beat Alessandri
Journal:  Int J Mol Sci       Date:  2016-01-11       Impact factor: 5.923

Review 9.  Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System.

Authors:  Eunju Leem; Kyoung Hoon Jeong; So-Yoon Won; Won-Ho Shin; Sang Ryong Kim
Journal:  Exp Neurobiol       Date:  2016-08-08       Impact factor: 3.261

10.  High CSF thrombin concentration and activity is associated with an unfavorable outcome in patients with intracerebral hemorrhage.

Authors:  Harald Krenzlin; Christina Frenz; Jan Schmitt; Julia Masomi-Bornwasser; Dominik Wesp; Darius Kalasauskas; Thomas Kerz; Johannes Lotz; Beat Alessandri; Florian Ringel; Naureen Keric
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.